S-Nitrosocaptopril
Alternative Names: SnoCapLatest Information Update: 27 Feb 2008
At a glance
- Originator Shiga University of Medical Science
- Developer GlaxoSmithKline; Shiga University of Medical Science
- Class Vasodilators
- Mechanism of Action ACE inhibitors; Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Angina pectoris; Heart failure; Hypertension; Ischaemic heart disorders
Most Recent Events
- 14 Jun 2001 No-Development-Reported for Hypertension in USA (IV)
- 23 Jan 2001 Glaxo Wellcome has merged with SmithKline Beecham to form GlaxoSmithKline
- 08 Sep 1998 Preclinical development for Hypertension in USA (IV)